Navigation Links
The Pittsburgh Life Sciences Greenhouse Announces New Chairman of the Board

PITTSBURGH, Dec. 2, 2010 /PRNewswire/ -- The Board of Directors of the Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth services to the region's life sciences enterprises, today announced the approval of the nomination of Peter M. DeComo as the new Chairman of the Board of the PLSG, effective immediately.  Mr. DeComo will replace Dr. D. Lansing Taylor who is stepping down after serving 3 years as Chairman and 8 years as a PLSG Board member.

In addition, it was announced that Michael Huff, Acting Secretary of Health, Commonwealth of Pennsylvania, Austin Burke, Secretary of DCED, Commonwealth of Pennsylvania and Gary G. Glausser, Managing Partner at Corridor Venture Partners and William R. Newlin, Chairman of Newlin Investment Company have been approved as members of the Board of Directors effective January 1, 2011.

In making the announcement, John W. Manzetti, PLSG President and CEO remarked, "Pete is an exceptional regional advocate for the development of life sciences innovation, a seasoned entrepreneur and an exemplary leader. We look forward to Pete's continued dedication to the life sciences and we welcome him as our new board chair."

As incoming Chairman of the Board Mr. DeComo said, "I am honored to work with such a tremendous group of board members and the PLSG team as we continue our work to establish the Pittsburgh region as a dominant player in the life sciences. We will work tirelessly to commercialize and fund life sciences technologies while providing an improved quality of life for the world's citizens."

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The PLSG invests in and supports the growth of biosciences companies in southwestern Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the Greater Pittsburgh region.

Peter M. DeComo, PLSG Chairman of the Board

Mr. DeComo is currently the Chairman and CEO at ALung Technologies, Inc.  In addition, Peter is Co-Founder and Chairman at ThermalTherapeutics, Inc., and a director at Clearcount Medical Solutions.  Prior to joining ALung Technologies, he was the Founder, Chairman and Chief Executive Officer at Renal Solutions, Inc. Previously, Mr. DeComo was the Chief Operating Officer of HemoTherapies Inc. and a Senior Vice President of the Infusion Therapy/Biotech Operating Division for Olsten Health Services. He received an M.S. and a B.S. in Healthcare Management from the University of Pittsburgh.

SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Precision Therapeutics President and CEO Sean McDonald Recognized as Pittsburgh Technology Council Tech 50 CEO of the Year
2. The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program
3. The Pittsburgh Life Sciences Greenhouse Invests $725K in Portfolio Companies
4. The Pittsburgh Life Sciences Greenhouse Adds Life Sciences Veterans to Executive Program
5. Pittsburgh Life Sciences Greenhouse Demonstrates a Regions Economic Resilience
6. The Pittsburgh Life Sciences Greenhouse Starts 2009 With Investment Momentum
7. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
8. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
9. Opening Dedication of the New John G. Rangos Sr. Research Center at the New Childrens Hospital of Pittsburgh of UPMC Campus in Lawrenceville
10. Pittsburgh Technology Council Announces Technology 50
11. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology:
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):